169 related articles for article (PubMed ID: 25954318)
1. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women.
Dording CM; Schettler PJ; Dalton ED; Parkin SR; Walker RS; Fehling KB; Fava M; Mischoulon D
Evid Based Complement Alternat Med; 2015; 2015():949036. PubMed ID: 25954318
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.
Dording CM; Fisher L; Papakostas G; Farabaugh A; Sonawalla S; Fava M; Mischoulon D
CNS Neurosci Ther; 2008; 14(3):182-91. PubMed ID: 18801111
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content.
Brooks NA; Wilcox G; Walker KZ; Ashton JF; Cox MB; Stojanovska L
Menopause; 2008; 15(6):1157-62. PubMed ID: 18784609
[TBL] [Abstract][Full Text] [Related]
4. Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial.
Zenico T; Cicero AF; Valmorri L; Mercuriali M; Bercovich E
Andrologia; 2009 Apr; 41(2):95-9. PubMed ID: 19260845
[TBL] [Abstract][Full Text] [Related]
5. Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial.
Clayton AH; Tourian KA; Focht K; Hwang E; Cheng RF; Thase ME
J Clin Psychiatry; 2015 May; 76(5):562-9. PubMed ID: 25375652
[TBL] [Abstract][Full Text] [Related]
6. Maca reduces blood pressure and depression, in a pilot study in postmenopausal women.
Stojanovska L; Law C; Lai B; Chung T; Nelson K; Day S; Apostolopoulos V; Haines C
Climacteric; 2015 Feb; 18(1):69-78. PubMed ID: 24931003
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.
Mahableshwarkar AR; Jacobsen PL; Chen Y
Curr Med Res Opin; 2013 Mar; 29(3):217-26. PubMed ID: 23252878
[TBL] [Abstract][Full Text] [Related]
8. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine.
Nakonezny PA; Byerly MJ; Rush AJ
J Sex Marital Ther; 2007; 33(3):203-16. PubMed ID: 17454518
[TBL] [Abstract][Full Text] [Related]
9. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men.
Gonzales GF; Córdova A; Vega K; Chung A; Villena A; Góñez C; Castillo S
Andrologia; 2002 Dec; 34(6):367-72. PubMed ID: 12472620
[TBL] [Abstract][Full Text] [Related]
10. Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double Blind, Randomized, Placebo-Controlled, Multi-Centre Clinical Study.
Meissner HO; Mscisz A; Reich-Bilinska H; Kapczynski W; Mrozikiewicz P; Bobkiewicz-Kozlowska T; Kedzia B; Lowicka A; Barchia I
Int J Biomed Sci; 2006 Dec; 2(4):360-74. PubMed ID: 23675005
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder.
Gommoll CP; Greenberg WM; Chen C
J Drug Assess; 2014; 3(1):10-9. PubMed ID: 27536449
[TBL] [Abstract][Full Text] [Related]
12. A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use.
Jespersen S; Berk M; Van Wyk C; Dean O; Dodd S; Szabo CP; Maud C
Int Clin Psychopharmacol; 2004 May; 19(3):161-4. PubMed ID: 15107659
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic interventions for antidepressant-induced sexual dysfunction: a systematic review and network meta-analysis of trials using the Arizona sexual experience scale.
Luft MJ; Dobson ET; Levine A; Croarkin PE; Strawn JR
CNS Spectr; 2021 Apr; ():1-10. PubMed ID: 33843553
[TBL] [Abstract][Full Text] [Related]
14. [Validation of Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) in a Spanish population].
Sierra JC; Vallejo-Medina P; Santos-Iglesias P; Lameiras Fernández M
Aten Primaria; 2012 Sep; 44(9):516-24. PubMed ID: 22551625
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo.
Clayton AH; Reddy S; Focht K; Musgnung J; Fayyad R
J Sex Med; 2013 Mar; 10(3):768-76. PubMed ID: 22905811
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
Pae CU; Marks DM; Masand PS; Peindl K; Hooper-Wood C; Han C; Mannelli P; Ciccone P; Patkar AA
Clin Neuropharmacol; 2009; 32(2):85-8. PubMed ID: 19512961
[TBL] [Abstract][Full Text] [Related]
17. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
18. Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind, randomized, Placebo-controlled, crossover configuration, outpatient study.
Meissner HO; Mscisz A; Reich-Bilinska H; Mrozikiewicz P; Bobkiewicz-Kozlowska T; Kedzia B; Lowicka A; Barchia I
Int J Biomed Sci; 2006 Dec; 2(4):375-94. PubMed ID: 23675006
[TBL] [Abstract][Full Text] [Related]
19. Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study.
Gonzales-Arimborgo C; Yupanqui I; Montero E; Alarcón-Yaquetto DE; Zevallos-Concha A; Caballero L; Gasco M; Zhao J; Khan IA; Gonzales GF
Pharmaceuticals (Basel); 2016 Aug; 9(3):. PubMed ID: 27548190
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
